Skip to main content
logo
Heidelberg Pharma AG (ETR:HPHA)
Germany flag Germany · Delayed Price · Currency is EUR
2.750
+0.010 (0.36%)
Apr 17, 2026, 5:35 PM CET

Heidelberg Pharma AG Revenue

In the fiscal year ending November 30, 2025, Heidelberg Pharma AG had annual revenue of 1.46M EUR, down -78.72%. Heidelberg Pharma AG had revenue of 21.44K in the quarter ending November 30, 2025, a decrease of -98.66%.

Revenue
1.46M
Revenue Growth
-78.72%
P/S Ratio
88.28
Revenue / Employee
12.78K
Employees
114
Market Cap
128.66M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Nov 30, 20251.46M-5.39M-78.72%
Nov 30, 20246.85M-3.01M-30.53%
Nov 30, 20239.86M-8.66M-46.75%
Nov 30, 202218.51M16.48M810.30%
Nov 30, 20212.03M-6.63M-76.53%
Nov 30, 2020 Pro Pro Pro
Nov 30, 2019 Pro Pro Pro
Nov 30, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bayer Aktiengesellschaft45.58B
Siemens Healthineers AG23.30B
Fresenius SE & Co. KGaA22.87B
Merck KGaA21.10B
MEDICLIN Aktiengesellschaft801.12M
M1 Kliniken AG354.98M
Stratec SE260.25M
FamiCord AG88.29M
Revenue Rankings

Heidelberg Pharma AG News

More News